comparemela.com

Latest Breaking News On - Institute for drug control - Page 4 : comparemela.com

Sputnik V cites tests in Hungary to prove reliability; denies claims by Slovak drug agency

Last Updated: Sputnik V Cites Tests In Hungary To Prove Reliability; Denies Claims By Slovak Drug Agency The makers of world’s first registered COVID-19 vaccine- SPUTNIK V, on May 7 informed that said vaccine proved reliable after undergoing trials in Hungary. In a recent development, the makers of world’s first registered COVID-19 vaccine- SPUTNIK V, on May 7 informed that said vaccine proved reliable after undergoing trials in Hungary as the Health Ministry of The Slovak Republic has granted approval of the same. The makers of Russia s SPUTNIK V COVID-19 vaccine clarified this approval by Slovakia’s drug watchdog- State Institute for Drug Control (SUKL) succeeded their previous dissent for the drug. Apparently, Slovak regulator- SUKL, in March, claimed SPUTNIK V they had received was not “the same vaccine reviewed in the Lancet”. As a result, Russia took back 600 of the 200,000 vaccine doses that were delivered to Slovakia in March in order to carry o

Brazil: Was there sloppiness with the Sputnik V vaccine?

news Brazil: Was there sloppiness with the Sputnik V vaccine? dw.com 04/05/2021 Alexander Freund Brazil has halted approval of Sputnik V, saying that a vector virus in the vaccine was not inactived and could cause severe colds. Russia has denied the story. © Carol Smiljan/ZUMA Wire/imago images Authorities in Slovakia and Brazil have raised questions about Sputnik V In Brazil, however, Sputnik V will not receive approval for the time being. During testing of the vaccine, the state drug agency Anvisa found indications that the vector virus Adenovirus 5 used in the second vaccination is not inactive and can therefore multiply.

Brazil: Was there sloppiness with the Sputnik V COVID vaccine? | Science| In-depth reporting on science and technology | DW

Brazil: Was there sloppiness with the Sputnik V COVID vaccine? Brazil has halted approval of Sputnik V, claiming that a vector virus in the vaccine was not inactive and could cause severe colds. Russia is denying the accusation. Authorities in Slovakia and Brazil have raised questions about Sputnik V In Brazil, however, Sputnik V will not receive approval for the time being. According to claims bythe state drug agency Anvisa  there are indications that the vector virus Adenovirus 5 used in the second vaccination is not inactive and can therefore multiply. This could be dangerous, especially for people with weak immune systems, because if the cold virus used as a carrier was not inactivated, then the patient is virtually directly injected with the pathogen and becomes ill, warned US virologist Angela Rasmussen  of the Center for Global Health Science and Security at Georgetown University on Twitter. 

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.